These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35422944)

  • 1. Inclusion complex of lurasidone hydrochloride with Sulfobutylether-β-cyclodextrin has enhanced oral bioavailability and no food effect.
    Wang J; Huang B; Dai J; Chen G; Ren L
    Am J Transl Res; 2022; 14(3):1495-1506. PubMed ID: 35422944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.
    Wang D; Chen G; Ren L
    AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mechanochemical inclusion of triamterene into sulfobutylether-β-cyclodextrin and its improved dissolution behavior.
    Maeda H; Shiobara R; Tanaka M; Kajinami A; Nakayama H
    Drug Dev Ind Pharm; 2021 Apr; 47(4):535-541. PubMed ID: 33185132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of sulfobutylether-β-cyclodextrin/glabridin inclusion complex for promoting bioactivities.
    Wang W; Tang K; Huang C; Liu A
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400082. PubMed ID: 38724255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L; Jing J; Chen G; Miao Y; Wei P
    J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications.
    Eid EEM; Almaiman AA; Alshehade SA; Alsalemi W; Kamran S; Suliman FO; Alshawsh MA
    Molecules; 2023 May; 28(10):. PubMed ID: 37241838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study.
    Ren L; Wang J; Chen G
    Drug Deliv; 2019 Dec; 26(1):309-317. PubMed ID: 30896265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complexes of trihexyphenidyl with natural and modified cyclodextrins.
    Maeda H; Tanaka R; Nakayama H
    Springerplus; 2015; 4():218. PubMed ID: 26020020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
    Ren L; Yang X; Guo W; Wang J; Chen G
    Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
    Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
    Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex.
    Ren L; Zhou Y; Wei P; Li M; Chen G
    AAPS PharmSciTech; 2014 Feb; 15(1):121-30. PubMed ID: 24166668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells.
    Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M
    J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the Anti-Leukemic Potential of Thymoquinone/Sulfobutylether-β-cyclodextrin (SBE-β-CD) Inclusion Complexes.
    Eid EEM; Alshehade SA; Almaiman AA; Kamran S; Lee VS; Alshawsh MA
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.
    Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C
    Front Chem; 2022; 10():930297. PubMed ID: 35800032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.
    Li H; Zhang G; Wang W; Chen C; Jiao L; Wu W
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.